Chinese General Practice ›› 2020, Vol. 23 ›› Issue (17): 2095-2101.DOI: 10.12114/j.issn.1007-9572.2019.00.366
Special Issue: 内分泌代谢性疾病最新文章合辑
• Monographic Research • Next Articles
Published:
2020-06-15
Online:
2020-06-15
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2019.00.366
[1]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4):292-344.DOI:10.19538/j.nk2018040108. Chinese Diabetes Society.Guidelines for the prevention and control of type 2 diabetes in China(2017 edition)[J].Chinese Journal of Practical Internal Medicine,2018,38(4):292-344.DOI:10.19538/j.nk2018040108. [2]纪立农.丰富中国2型糖尿病防治措施的临床证据链,建立基于中国人群证据的糖尿病防治指南——纪念第1版《中国2型糖尿病防治指南》发布10周年[J].中国糖尿病杂志,2014,22(1):1-4.DOI:10.3969/j.issn.1006-6187.2014.01.001. JI L N.Develop Chinese diabetes guidelines from clinical evidence in China——marking the tenth anniversary of the first edition of Chinese diabetes guidelines for type 2 diabetes[J].Chinese Journal of Diabetes,2014,22(1):1-4.DOI:10.3969/j.issn.1006-6187.2014.01.001. [3]WANG L M,GAO P,ZHANG M,et al.Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013[J].JAMA,2017,317(24):2515-2523.DOI:10.1001/jama.2017.7596. [4]DANESHGARI F,LIU G M,BIRDER L,et al.Diabetic bladder dysfunction:current translational knowledge[J].J Urol,2009,182(6 Suppl):S18-26.DOI:10.1016/j.juro.2009.08.070. [5]FRIMODT-M?LLER C.Diabetic cystopathy:epidemiology and related disorders[J].Ann Intern Med,1980,92(2_Part_2):318.DOI:10.7326/0003-4819-92-2-318. [6]FRIMODT-M?LLER C.Diabetic cystopathy.A review of the urodynamic and clinical features of neurogenic bladder dysfunction in diabetes mellitus[J].Dan Med Bull,1978,25(2):49-60. [7]顾士芬.糖尿病性膀胱病14例分析[J].河南医药信息,1996,17(3):5.http://www.cnki.com.cn/Article/CJFDTotal-HYYX603.002.htm [8]唐尧.糖尿病膀胱[J].铁道医学,1985,13(2):112-114. [9]MALIK R D,COHN J A,VOLSKY J,et al.A modern comparison of urodynamic findings in diabetic versus nondiabetic women[J].Female Pelvic Med Reconstr Surg,2018.DOI:10.1097/SPV.0000000000000586. [10]LEE W C,WU H P,TAI T Y,et al.Investigation of urodynamic characteristics and bladder sensory function in the early stages of diabetic bladder dysfunction in women with type 2 diabetes[J].J Urol,2009,181(1):198-203.DOI:10.1016/j.juro.2008.09.021. [11]HE C X,YUAN Z Y,YAN S B,et al.Clinical and urodynamic evaluation of women referred with diabetes mellitus[J].Int Urogynecol J,2014,25(7):979-983.DOI:10.1007/s00192-014-2354-5. [12]谈博,连大卫,黄涌鑫,等.糖尿病膀胱功能障碍小鼠的膀胱功能及尿动力学改变[J].广州中医药大学学报,2016,33(4):573-578.DOI:10.13359/j.cnki.gzxbtcm.2016.04.030. TAN B,LIAN D W,HUANG Y X,et al.Changes of bladder function and urodynamics of diabetic cystopathy model mice[J].Journal of Guangzhou University of Traditional Chinese Medicine,2016,33(4):573-578.DOI:10.13359/j.cnki.gzxbtcm.2016.04.030. [13]NICHOLS G A,BRODOVICZ K G,KIMES T M,et al.Prevalence and incidence of urinary tract and genital infections among patients with and without type 2 diabetes[J].J Diabetes Complicat,2017,31(11):1587-1591.DOI:10.1016/j.jdiacomp.2017.07.018. [14]WILKE T,BOETTGER B,BERG B,et al.Epidemiology of urinary tract infections in type 2 diabetes mellitus patients:an analysis based on a large sample of 456,586 German T2DM patients[J].J Diabetes Complicat,2015,29(8):1015-1023.DOI:10.1016/j.jdiacomp.2015.08.021. [15]YU S S,FU A Z,QIU Y,et al.Disease burden of urinary tract infections among type 2 diabetes mellitus patients in the US[J].J Diabetes Complicat,2014,28(5):621-626.DOI:10.1016/j.jdiacomp.2014.03.012. [16]陈嘉炜,曹瑛,陈杨,等.女性Ⅱ型糖尿病患者尿液菌群特征与非感染性下尿路症状的关系[J].临床泌尿外科杂志,2018,33(1):16-19.DOI:10.13201/j.issn.1001-1420.2018.01.004. CHEN J W,CAO Y,CHEN Y,et al.Relationship between characteristics of urinary microbiome and non-infectious lower urinary tract symptoms in female type Ⅱ diabetic patients[J].Journal of Clinical Urology,2018,33(1):16-19.DOI:10.13201/j.issn.1001-1420.2018.01.004. [17]PALLESCHI G,PASTORE A L,MAGGIONI C,et al.Overactive bladder in diabetes mellitus patients:a questionnaire-based observational investigation[J].World J Urol,2014,32(4):1021-1025.DOI:10.1007/s00345-013-1175-3. [18]CHANCELLOR M B.The overactive bladder progression to underactive bladder hypothesis[J].Int Urol Nephrol,2014,46(Suppl 1):S23-27.DOI:10.1007/s11255-014-0778-y. [19]SHIN Y S,ON J W,KIM M K.Clinical significance of diabetes mellitus on detrusor functionality on stress urinary incontinent women without bladder outlet obstruction[J].Int Urogynecol J,2016,27(10):1557-1561.DOI:10.1007/s00192-016-2997-5. [20]GIACCO F,BROWNLEE M.Oxidative stress and diabetic complications[J].Circ Res,2010,107(9):1058-1070.DOI:10.1161/CIRCRESAHA.110.223545. [21]BROWNLEE M.The pathobiology of diabetic complications:a unifying mechanism[J].Diabetes,2005,54(6):1615-1625.DOI:10.2337/diabetes.54.6.1615. [22]BESHAY E,CARRIER S.Oxidative stress plays a role in diabetes-induced bladder dysfunction in a rat model[J].Urology,2004,64(5):1062-1067.DOI:10.1016/j.urology.2004.06.021. [23]XIAO N,WANG Z P,HUANG Y X,et al.Roles of polyuria and hyperglycemia in bladder dysfunction in diabetes[J].J Urol,2013,189(3):1130-1136.DOI:10.1016/j.juro.2012.08.222. [24]KANIKA N D,CHANG J,TONG Y H,et al.Oxidative stress status accompanying diabetic bladder cystopathy results in the activation of protein degradation pathways[J].BJU Int,2011,107(10):1676-1684.DOI:10.1111/j.1464-410X.2010.09655.x. [25]WANG Y,DENG G G,DAVIES K P.Novel insights into development of diabetic bladder disorder provided by metabolomic analysis of the rat nondiabetic and diabetic detrusor and urothelial layer[J].Am J Physiol Endocrinol Metab,2016,311(2):E471-479.DOI:10.1152/ajpendo.00134.2016. [26]TONG Y C,CHENG J T.Alteration of M(3) subtype muscarinic receptors in the diabetic rat urinary bladder[J].Pharmacology,2002,64(3):148-151.DOI:10.1159/000056164. [27]CHENG J T,YU B C,TONG Y C.Changes of M3-muscarinic receptor protein and mRNA expressions in the bladder urothelium and muscle layer of streptozotocin-induced diabetic rats[J].Neurosci Lett,2007,423(1):1-5.DOI:10.1016/j.neulet.2007.05.062. [28]LEIRIA L O,MóNICA F Z,CARVALHO F D,et al.Functional,morphological and molecular characterization of bladder dysfunction in streptozotocin-induced diabetic mice:evidence of a role for L-type voltage-operated Ca2+ channels[J].Br J Pharmacol,2011,163(6):1276-1288.DOI:10.1111/j.1476-5381.2011.01311.x. [29]GONULALAN U,KOSAN M,HAFEZ G,et al.The effect of diabetes mellitus on α1-adrenergic receptor subtypes in the bladder of rats[J].Urology,2012,80(4):951.e9-951.16.DOI:10.1016/j.urology.2012.06.019. [30]REN L M,ZHUO Y J,HAO Z S,et al.Berberine improves neurogenic contractile response of bladder detrusor muscle in streptozotocin-induced diabetic rats[J].J Ethnopharmacol,2013,150(3):1128-1136.DOI:10.1016/j.jep.2013.10.039. [31]NITTI V W.Duloxetine:a new pharmacologic therapy for stress urinary incontinence[J].Rev Urol,2004,6(Suppl 3):S48-55. [32]SACCO E,RECUPERO S,BIENTINESI R,et al.Pioneering drugs for overactive bladder and detrusor overactivity:ongoing research and future directions[J].WJOG,2015,4(2):24.DOI:10.5317/wjog.v4.i2.24. [33]KADOW B T,TYAGI P,CHERMANSKY C J.Neurogenic causes of detrusor underactivity[J].Curr Bladder Dysfunct Rep,2015,10(4):325-331.DOI:10.1007/s11884-015-0331-6. [34]SASAKI K,CHANCELLOR M B,PHELAN M W,et al.Diabetic cystopathy correlates with a long-term decrease in nerve growth factor levels in the bladder and lumbosacral dorsal root ganglia[J].J Urol,2002,168(3):1259-1264.DOI:10.1097/01.ju.0000023400.17372.3e. [35]SHAROPOV B R,GULAK K L,PHILYPPOV I B,et al.TRPV1 alterations in urinary bladder dysfunction in a rat model of STZ-induced diabetes[J].Life Sci,2018,193:207-213.DOI:10.1016/j.lfs.2017.10.042. [36]HUGHES F M Jr,HIRSHMAN N A,INOUYE B M,et al.NLRP3 promotes diabetic bladder dysfunction and changes in symptom-specific bladder innervation[J].Diabetes,2019,68(2):430-440.DOI:10.2337/db18-0845. [37]BIRDER L A,ANDERSSON K E,KANAI A J,et al.Urothelial mucosal signaling and the overactive bladder-ICI-RS 2013[J].Neurourol Urodyn,2014,33(5):597-601.DOI:10.1002/nau.22604. [38]LEE S,ROSE'MEYER R,MCDERMOTT C,et al.Diabetes-induced alterations in urothelium function:enhanced ATP release and nerve-evoked contractions in the streptozotocin rat bladder[J].Clin Exp Pharmacol Physiol,2018,45(11):1161-1169.DOI:10.1111/1440-1681.13003. [39]YANG Z G,DOLBER P C,FRASER M O.Diabetic urethropathy compounds the effects of diabetic cystopathy[J].J Urol,2007,178(5):2213-2219.DOI:10.1016/j.juro.2007.06.042. [40]王东文,双卫兵,吴博威.糖尿病患者膀胱功能改变的临床研究[J].临床泌尿外科杂志,2004,19(11):646-648.DOI:10.3969/j.issn.1001-1420.2004.11.003. WANG D W,SHUANG W B,WU B W.The study of bladder dysfunction in diabetes mellitus[J].Journal of Clinical Urology,2004,19(11):646-648.DOI:10.3969/j.issn.1001-1420.2004.11.003. [41]CHEN S C,LAI C H,FAN W J,et al.Pudendal neuromodulation improves voiding efficiency in diabetic rats[J].Neurourol Urodyn,2013,32(3):293-300.DOI:10.1002/nau.22280. [42]HSIEH T H,LIN Y T,CHEN S C,et al.Chronic pudendal neuromodulation using an implantable microstimulator improves voiding function in diabetic rats[J].J Neural Eng,2016,13(4):046001.DOI:10.1088/1741-2560/13/4/046001. [43]杨斌斌.不同频率与强度阴部神经电刺激对糖尿病膀胱尿动力学表现的影响[D].杭州:浙江大学,2017.http://cdmd.cnki.com.cn/Article/CDMD-10335-1017119283.htm. [44]关红.经皮低频脉冲电刺激对糖尿病膀胱患者的作用分析[J].中国实用医药,2014,9(35):60-61.DOI:10.14163/j.cnki.11-5547/r.2014.35.041.http://www.cnki.com.cn/Article/CJFDTotal-ZSSA201435041.htm. [45]WANG H S,OH B S,WANG B H,et al.Low-intensity extracorporeal shockwave therapy ameliorates diabetic underactive bladder in streptozotocin-induced diabetic rats[J].BJU Int,2018,122(3):490-500.DOI:10.1111/bju.14216. [46]JIN Y,XU L N,ZHAO Y,et al.Endogenous stem cells were recruited by defocused low-energy shock wave in treating diabetic bladder dysfunction[J].Stem Cell Rev,2017,13(2):287-298.DOI:10.1007/s12015-016-9705-1. [47]HUANG Y,DING L C,SHAO Y P,et al.Integrin-linked kinase improves functional recovery of diabetic cystopathy and mesenchymal stem cell survival and engraftment in rats[J].Can J Diabetes,2017,41(3):312-321.DOI:10.1016/j.jcjd.2016.11.002. [48]GOPINATH C,PONSAERTS P,FRANSEN E,et al.Smooth muscle cell transplantation improves bladder contractile function in streptozocin-induced diabetic rats[J].Cytotherapy,2013,15(7):869-878.DOI:10.1016/j.jcyt.2013.02.015. [49]LI Y H,WEN Y,WANG Z,et al.Smooth muscle progenitor cells derived from human pluripotent stem cells induce histologic changes in injured urethral sphincter[J].Stem Cells Transl Med,2016,5(12):1719-1729.DOI:10.5966/sctm.2016-0035. [50]XU J,XU H,YU Y,et al.Combination of luteolin and solifenacin improves urinary dysfunction induced by diabetic cystopathy in rats[J].Med Sci Monit,2018,24:1441-1448. [51]张昆,邝芳,闫飞,等.肌苷对糖尿病性膀胱病的保护作用及机制[J].医学研究生学报,2018,31(1):5-12.DOI:10.16571/j.cnki.1008-8199.2018.01.002. ZHANG K,KUANG F,YAN F,et al.Inosine protects bladder structure and function in rats with diabetic cystopathy[J].Journal of Medical Postgraduates,2018,31(1):5-12.DOI:10.16571/j.cnki.1008-8199.2018.01.002. [52]GREWAL A S,BHARDWAJ S,PANDITA D,et al.Updates on aldose reductase inhibitors for management of diabetic complications and non-diabetic diseases[J].Mini Rev Med Chem,2016,16(2):120-162. [53]SURESHA B S,VASANTHA K Y,SATTUR A P,et al.Beneficial influence of fungal metabolite nigerloxin on diabetes-induced oxidative stress in experimental rats[J].Can J Physiol Pharmacol,2013,91(2):149-156.DOI:10.1139/cjpp-2012-0241. [54]ARRELLANO-VALDEZ F,URRUTIA-OSORIO M,ARROYO C,et al.A comprehensive review of urologic complications in patients with diabetes[J].Springerplus,2014,3:549.DOI:10.1186/2193-1801-3-549. [55]JAYABALAN B,LOW L L.Vitamin B supplementation for diabetic peripheral neuropathy[J].Singapore Med J,2016,57(2):55-59.DOI:10.11622/smedj.2016027. [56]吴波,李力.单唾液酸四己糖神经节苷脂钠治疗糖尿病周围神经病变80例疗效分析[J].中国老年学杂志,2011,31(5):885-886.DOI:10.3969/j.issn.1005-9202.2011.05.076.http://www.cnki.com.cn/Article/CJFDTotal-ZLXZ201105078.htm. |
[1] | TIAN Chen, LIU Jianing, TIAN Jinhui, GE Long. Living Systematic Reviews: Methods and Processes for Development [J]. Chinese General Practice, 2025, 28(30): 3853-3860. |
[2] | WANG Tingting, TANG Yong, ZHANG Wenke, LI Zhigang. Research Progress on Exercise Intervention of Hyperuricemia [J]. Chinese General Practice, 2025, 28(30): 3841-3846. |
[3] | ZHANG Peng, LIU Lidi, ZHANG Ying, YANG Ziyu, LIU Changming, TANG Yijun, LIAO Xiaoyang, JIA Yu. Interpretation and Clinical Implications of the 2024 Italian Guidelines for the Management of Adult Individuals with Overweight and Obesity and Metabolic Comorbidities That are Resistant to Behavioral Treatment [J]. Chinese General Practice, 2025, 28(30): 3747-3752. |
[4] | ZHOU Sheng, DENG Changsheng, ZOU Guanyang, SONG Jianping. Research Progress on the Pathogenesis of Complications of Malaria in Cardiovascular Diseases [J]. Chinese General Practice, 2025, 28(27): 3466-3472. |
[5] | ZHANG Tianyu, YU Haibo, CHEN Fei, LI Xin, ZHANG Jiajia, ZHAN Xiaokai, SHEN Man, TANG Ran, FAN Sibin, ZHAO Fengyi, HUANG Zhongxia. Meta-analysis of the Efficacy and Safety of Systemic Treatment for POEMS Syndrome [J]. Chinese General Practice, 2025, 28(27): 3447-3455. |
[6] | WANG Yajing, DUAN Xiaoyang, HOU Ran, HUANG Yajie, SHI Jian. Advances in Targeted Combination Therapy for Patients with Brain Metastases from EGFR-mutated Non-small Cell Lung Cancer [J]. Chinese General Practice, 2025, 28(26): 3328-3337. |
[7] | HUANG Yulin, WANG Haoyun, LI Yanmei, XIAO Xueying. Symptom Clusters in Gastric Cancer Patients Receiving Chemotherapy: a Scoping Review [J]. Chinese General Practice, 2025, 28(26): 3338-3344. |
[8] | ZHI Congcong, LI Xue, CHENG Yicheng, WANG Xiaolong, ZHENG Lihua. Guidelines for Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Hemorrhoids (2025 Edition) [J]. Chinese General Practice, 2025, 28(26): 3217-3228. |
[9] | LIU Yinyin, SUI Hongping, LI Tingting, JIANG Tongtong, SHI Tieying, XIA Yunlong. Advances in Risk Prediction Models for Cardiotoxicity Associated with Breast Cancer Treatment [J]. Chinese General Practice, 2025, 28(24): 3072-3078. |
[10] | LI Miaoxiu, ZHU Bowen, KONG Lingjun, FANG Min. Progress in Research on Clinical Assessment Tools for Conservative Treatment of Adolescent Idiopathic Scoliosis [J]. Chinese General Practice, 2025, 28(24): 3079-3088. |
[11] | XIAO Yao, WAN Jun. Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants [J]. Chinese General Practice, 2025, 28(24): 3066-3071. |
[12] | RUAN Wanbai, LI Junfeng, YIN Yanmei, PENG Lei, ZHU Kexiang. Research Progress of Targeted Therapy and Immunotherapy for Pancreatic Cancer [J]. Chinese General Practice, 2025, 28(23): 2950-2960. |
[13] | ZHOU Lianpeng, LI Weifeng, DONG Xingang, WANG Xiaoyuan. Research Progress on the Role of Copper Homeostasis Regulation Mechanism in Cognition Disorder [J]. Chinese General Practice, 2025, 28(23): 2941-2949. |
[14] | YANG Handan, QIAO Wen, HE Shu, CHEN Yi, TONG Yunmei. The Impact of Acceptance and Commitment Therapy Combined with Sertraline on Depressive Mood, Suicidal Ideation, and Sleep Quality of Adolescents with Depression [J]. Chinese General Practice, 2025, 28(22): 2813-2818. |
[15] | DONG Haocheng, HAO Xiao, AN Dong, LI Haohan, LI Shuren. Research Progress of Heart Failure with Supra-normal Ejection Fraction [J]. Chinese General Practice, 2025, 28(21): 2692-2696. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||